Skip to main content
Monday, November 16, 2026Nov 16

Dalton, Georgia, to offer COVID-19 antibody treatment at drive-in clinic

THUMBNAIL Dalton (Georgia) City Council member Annalee Harlan speaks about new monoclonal antibody treatments to be offered by the city starting as soon as Thursday. Staff photo by Kelcey Caulder
THUMBNAIL Dalton (Georgia) City Council member Annalee Harlan speaks about new monoclonal antibody treatments to be offered by the city starting as soon as Thursday. Staff photo by Kelcey Caulder
photo Dalton (Georgia) City Council member Annalee Harlan speaks about new monoclonal antibody treatments to be offered by the city starting as soon as Thursday. Staff photo by Kelcey Caulder

DALTON, GA. – The city of Dalton, Georgia, will offer free monoclonal antibody treatments to COVID-19 patients on a drive-in basis beginning as soon as Thursday. The treatment, commonly referred to by its manufacturer’s name “Regeneron,” can be given to early diagnosed COVID-19 patients and has been shown to reduce hospitalizations or deaths when administered within seven days of the first onset of illness.

In the past, the treatment was administered intravenously on an outpatient basis only. Now, it can be offered via syringe injection.

Dalton City Council member Annalee Harlan, who helped lead the push to make the monoclonal antibody treatment available locally, said it is not intended to replace vaccination. It is intended to act as a “Band-Aid” while the push for vaccination continues.

“Please hear me clearly when I say I’m excited we have access to this drug therapy, because we need that right now, here and across our country, to mitigate the burden on our hospital systems, but it is only a Band-Aid to get us through,” Harlan said. “We are grateful to have this tool in our belt, but vaccination is the key tool to make sure we come out of this pandemic.”

The U.S. Food and Drug Administration approved the use of Regeneron’s monoclonal antibody treatments for patients 12 or older through an Emergency Use Authorization on Nov. 21. Former President Donald Trump received the antibody treatment after contracting the coronavirus in October.